The Filing Desk

Harrow vs Rigel Pharmaceuticals

Harrow HROW · Rigel Pharmaceuticals RIGL · Pharmaceuticals

Rigel Pharmaceuticals reported revenue of $294 million in fiscal 2025, about the same as Harrow's $272 million in fiscal 2025. Harrow's revenue grew 36.4% in its latest year, and Rigel Pharmaceuticals' grew 64.2%. Harrow had an operating margin of 11.2%, against 42.6% at Rigel Pharmaceuticals.

Side by side

HarrowRigel Pharmaceuticals
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$272M$294M
Revenue growth36.4%64.2%
Revenue growth a year, last 5 years41.0%22.1%
Gross margin75.0%93.3%
Operating margin11.2%42.6%
Net margin−1.9%124.7%
Free cash flow$43M—
Free cash flow margin15.8%—
Return on capital—91.3%
Net debt to EBITDA5.5x−0.8x
Dividends and buybacks$0M$0M
Change in diluted share count3.1%6.5%
Last close$30.12$44.46
P/E at the last close—2.8×
Insider trades, last 12 months——
Piotroski F-score6 of 97 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
HarrowRigel Pharmaceuticals
Operating margin
Percent of revenue
HarrowRigel Pharmaceuticals
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HarrowRigel Pharmaceuticals

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Harrow and Rigel Pharmaceuticals pages.